{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:13:49Z","timestamp":1789676029489,"version":"4.0.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2024 Shaanxi Provincial Health Commission High-level Talent (Team) Cultivation Program Project","award":["XYFYPT-RC-02"],"award-info":[{"award-number":["XYFYPT-RC-02"]}]},{"name":"Shaanxi Provincial Department of Education Special Service Project","award":["24JC079"],"award-info":[{"award-number":["24JC079"]}]},{"name":"Xi'an Weiyang District Project","award":["202412"],"award-info":[{"award-number":["202412"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03383-9","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:01:53Z","timestamp":1763136113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lactate and gastric cancer immunotherapy from regulatory mechanisms to therapeutic strategies: a critical review"],"prefix":"10.1186","volume":"30","author":[{"given":"Yuanzhu","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixing","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QingLing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-2472","authenticated-orcid":false,"given":"Manli","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3945-3387","authenticated-orcid":false,"given":"Mingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"11","key":"3383_CR1","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s10495-024-02020-w","volume":"29","author":"K Lin","year":"2024","unstructured":"Lin K, Lin X, Luo F. IGF2BP3 boosts lactate generation to accelerate gastric cancer immune evasion. Apoptosis. 2024;29(11):2147\u20132160.","journal-title":"Apoptosis"},{"issue":"1","key":"3383_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01527-8","volume":"17","author":"J Lin","year":"2024","unstructured":"Lin J, Rao D, Zhang M, Gao Q. Metabolic reprogramming in the tumor microenvironment of liver cancer. J Hematol Oncol. 2024;17(1):6.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3383_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000529707","volume":"10","author":"T Namikawa","year":"2023","unstructured":"Namikawa T, Utsunomiya M, Yokota K, Munekage M, Uemura S, Maeda H, et al. Association between serum zinc levels and clinicopathological characteristics in patients with gastric cancer. Gastrointest Tumors. 2023;10(1):6\u201313.","journal-title":"Gastrointest Tumors"},{"issue":"12","key":"3383_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","volume":"50","author":"P Darvin","year":"2018","unstructured":"Darvin P, Toor SM, Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med. 2018;50(12):1\u201311.","journal-title":"Exp Mol Med"},{"issue":"1","key":"3383_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01522-4","volume":"8","author":"Q Sun","year":"2023","unstructured":"Sun Q, Hong Z, Zhang C, Wang L, Han Z, Ma D. Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends. Sig Transduct Target Ther. 2023;8(1):320.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"3383_CR6","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1111\/cas.15497","volume":"113","author":"J Nagasaki","year":"2022","unstructured":"Nagasaki J, Ishino T, Togashi Y. Mechanisms of resistance to immune checkpoint inhibitors. Cancer Sci. 2022;113(10):3303\u20133312.","journal-title":"Cancer Sci"},{"issue":"8","key":"3383_CR7","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma P, Goswami S, Raychaudhuri D, Siddiqui BA, Singh P, Nagarajan A, et al. Immune checkpoint therapy\u2014current perspectives and future directions. Cell. 2023;186(8):1652\u20131669.","journal-title":"Cell"},{"issue":"12","key":"3383_CR8","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1111\/febs.17423","volume":"292","author":"M Iozzo","year":"2025","unstructured":"Iozzo M, Comito G, Ippolito L, Sandrini G, Pardella E, Pranzini E, et al. Sex-related changes in lactate dehydrogenase a expression differently impact the immune response in melanoma. FEBS J. 2025;292(12):3056\u20133071.","journal-title":"FEBS J"},{"issue":"7851","key":"3383_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, et al. Metabolic support of tumor-infiltrating regulatory T cells by lactic acid. Nature. 2021;591(7851):645\u2013651.","journal-title":"Nature"},{"issue":"7788","key":"3383_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","volume":"577","author":"A Tasdogan","year":"2020","unstructured":"Tasdogan A, Faubert B, Ramesh V, Ubellacker JM, Shen B, Solmonson A, et al. Metabolic heterogeneity confers differences in melanoma metastatic potential. Nature. 2020;577(7788):115\u2013120.","journal-title":"Nature"},{"issue":"46","key":"3383_CR11","doi-asserted-by":"publisher","first-page":"eabi8602","DOI":"10.1126\/sciadv.abi8602","volume":"7","author":"JT Noe","year":"2021","unstructured":"Noe JT, Rendon BE, Geller AE, Conroy LR, Morrissey SM, Young LEA, et al. Lactate supports a metabolic-epigenetic link in macrophage polarization. Sci Adv. 2021;7(46):eabi8602.","journal-title":"Sci Adv"},{"issue":"1","key":"3383_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46118-w","volume":"15","author":"M He","year":"2024","unstructured":"He M, Liu Y, Chen S, Deng H, Feng C, Qiao S, et al. Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma. Nat Commun. 2024;15(1):1754.","journal-title":"Nat Commun"},{"key":"3383_CR13","first-page":"1","volume":"2022","author":"Y Gao","year":"2022","unstructured":"Gao Y, Zhou H, Liu G, Wu J, Yuan Y, Shang A. Tumor microenvironment: Lactic acid promotes tumor development. J Immunol Res. 2022;2022:1\u20138.","journal-title":"J Immunol Res"},{"key":"3383_CR14","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang Z, Wang J, Chen C, Tang X, Zhu J, et al. Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review.\u00a0Onco Targets Ther\u00a0.2019;12:1195\u20131204.","DOI":"10.2147\/OTT.S189687"},{"key":"3383_CR15","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21(10):669\u2013680.","DOI":"10.1038\/s41568-021-00378-6"},{"key":"3383_CR16","doi-asserted-by":"crossref","unstructured":"Hu XT, Wu XF, Xu JY, Xu X. Lactate-mediated lactylation in human health and diseases: progress and remaining challenges. J Adv Res. 2024;75:229-248.","DOI":"10.1016\/j.jare.2024.11.010"},{"key":"3383_CR17","doi-asserted-by":"crossref","unstructured":"Liu X, Li S, Cui Q, Guo B, Ding W, Liu J, et al. Activation of GPR81 by lactate drives tumour-induced cachexia. Nat Metab. 2024;6(4):708\u2013723.","DOI":"10.1038\/s42255-024-01011-0"},{"key":"3383_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107451","volume":"206","author":"TP Brown","year":"2020","unstructured":"Brown TP, Ganapathy V. Lactate\/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and Warburg phenomenon. Pharmacol Ther. 2020;206:107451.","journal-title":"Pharmacol Ther"},{"key":"3383_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2023.100740","volume":"31","author":"Z Li","year":"2023","unstructured":"Li Z, Cui J. Targeting the lactic acid metabolic pathway for antitumor therapy. Mol Ther Oncolytics. 2023;31:100740.","journal-title":"Mol Ther Oncolytics"},{"issue":"5","key":"3383_CR20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1053\/j.gastro.2024.05.005","volume":"167","author":"S Rauth","year":"2024","unstructured":"Rauth S, Malafa M, Ponnusamy MP, Batra SK. Emerging trends in gastrointestinal cancer targeted therapies: harnessing tumor microenvironment, immune factors, and metabolomics insights. Gastroenterology. 2024;167(5):867\u2013884.","journal-title":"Gastroenterology"},{"key":"3383_CR21","doi-asserted-by":"crossref","unstructured":"Hu X, Wu X, Xu J, Xu X. Lactate-mediated lactylation in human health and diseases: Progress and remaining challenges. J Adv Res. 2025;75:229-248.","DOI":"10.1016\/j.jare.2024.11.010"},{"issue":"1","key":"3383_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, et al. Lactate and lactylation in cancer.  Signal Transduct Target Ther.\u00a02025;10(1):38.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"3383_CR23","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.1038\/s41467-022-32871-3","volume":"13","author":"T Feng","year":"2022","unstructured":"Feng T, Zhao X, Gu P, Yang W, Wang C, Guo Q, et al. Adipocyte-derived lactate is a signalling metabolite that potentiates adipose macrophage inflammation via targeting PHD2. Nat Commun. 2022;13(1):5208.","journal-title":"Nat Commun"},{"issue":"8","key":"3383_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.371","volume":"8","author":"J Zhou","year":"2017","unstructured":"Zhou J, Yao W, Li C, Wu W, Li Q, Liu H. Administration of follicle-stimulating hormone induces autophagy via upregulation of HIF-1\u03b1 in mouse granulosa cells. Cell Death Dis. 2017;8(8):e3001\u2013e3001.","journal-title":"Cell Death Dis"},{"issue":"12","key":"3383_CR25","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cels.2022.11.003","volume":"13","author":"Kshitiz","year":"2022","unstructured":"Kshitiz, Afzal J, Suhail Y, Chang H, Hubbi ME, Hamidzadeh A, et al. Lactate-dependent chaperone-mediated autophagy induces oscillatory HIF-1\u03b1 activity promoting proliferation of hypoxic cells. Cell Syst. 2022;13(12):1048-1064.e7.","journal-title":"Cell Syst"},{"issue":"1","key":"3383_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/imr.12982","volume":"302","author":"M Desbois","year":"2021","unstructured":"Desbois M, Wang Y. Cancer-associated fibroblasts: key players in shaping the tumor immune microenvironment. Immunol Rev. 2021;302(1):241\u2013258.","journal-title":"Immunol Rev"},{"issue":"7","key":"3383_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1440166","volume":"7","author":"P Xiao","year":"2018","unstructured":"Xiao P, Long X, Zhang L, Ye Y, Guo J, Liu P, et al. Neurotensin\/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of tumor-associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells. Oncoimmunology. 2018;7(7):e1440166.","journal-title":"Oncoimmunology"},{"issue":"8","key":"3383_CR28","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/1878-0261.13454","volume":"17","author":"M Bruch-Oms","year":"2023","unstructured":"Bruch-Oms M, Olivera-Salguero R, Mazzolini R, Del Valle-P\u00e9rez B, Mayo-Gonz\u00e1lez P, Beteta \u00c1, et al. Analyzing the role of cancer-associated fibroblast activation on macrophage polarization. Mol Oncol. 2023;17(8):1492\u20131513.","journal-title":"Mol Oncol"},{"issue":"12","key":"3383_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110986","volume":"39","author":"J Gu","year":"2022","unstructured":"Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X, et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells. Cell Rep. 2022;39(12):110986.","journal-title":"Cell Rep"},{"issue":"2","key":"3383_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40(2):201-218.e9.","journal-title":"Cancer Cell"},{"issue":"7779","key":"3383_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u2013580.","journal-title":"Nature"},{"key":"3383_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106270","volume":"181","author":"L Pan","year":"2022","unstructured":"Pan L, Feng F, Wu J, Fan S, Han J, Wang S, et al. Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. Pharmacol Res. 2022;181:106270.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3383_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03429-8","volume":"24","author":"G Wang","year":"2024","unstructured":"Wang G, Zou X, Chen Q, Nong W, Miao W, Luo H, et al. The relationship and clinical significance of lactylation modification in digestive system tumors. Cancer Cell Int. 2024;24(1):246.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"3383_CR34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader JE, Voss K, Rathmell JC. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol Cell. 2020;78(6):1019\u20131033.","journal-title":"Mol Cell"},{"issue":"11","key":"3383_CR35","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/s41590-024-01985-9","volume":"25","author":"D Raychaudhuri","year":"2024","unstructured":"Raychaudhuri D, Singh P, Chakraborty B, Hennessey M, Tannir AJ, Byregowda S, et al. Histone lactylation drives CD8+ T cell metabolism and function. Nat Immunol. 2024;25(11):2140\u20132151.","journal-title":"Nat Immunol"},{"issue":"1","key":"3383_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10120-019-00983-3","volume":"23","author":"S Pernot","year":"2020","unstructured":"Pernot S, Terme M, Radosevic-Robin N, Castan F, Badoual C, Marcheteau E, et al. Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance. Gastric Cancer. 2020;23(1):73\u201381.","journal-title":"Gastric Cancer"},{"issue":"1","key":"3383_CR37","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12967-024-05134-6","volume":"22","author":"Y Chen","year":"2024","unstructured":"Chen Y, Yu D, Qian H, Shi Y, Tao Z. CD8+ T cell-based cancer immunotherapy. J Transl Med. 2024;22(1):394.","journal-title":"J Transl Med"},{"key":"3383_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.molimm.2019.01.014","volume":"107","author":"T Yajima","year":"2019","unstructured":"Yajima T, Hoshino K, Muranushi R, Mogi A, Onozato R, Yamaki E, et al. Fas\/FasL signaling is critical for the survival of exhausted antigen-specific CD8+ T cells during tumor immune response. Mol Immunol. 2019;107:97\u2013105.","journal-title":"Mol Immunol"},{"issue":"762","key":"3383_CR39","doi-asserted-by":"publisher","first-page":"eadk7399","DOI":"10.1126\/scitranslmed.adk7399","volume":"16","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang F, Peng D, Zhang D, Liu L, Wei J, et al. Activation and antitumor immunity of CD8+ T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid. Sci Transl Med. 2024;16(762):eadk7399.","journal-title":"Sci Transl Med."},{"issue":"12","key":"3383_CR40","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","volume":"25","author":"RM Peralta","year":"2024","unstructured":"Peralta RM, Xie B, Lontos K, Nieves-Rosado H, Spahr K, Joshi S, et al. Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism. Nat Immunol. 2024;25(12):2297\u20132307.","journal-title":"Nat Immunol"},{"issue":"7","key":"3383_CR41","doi-asserted-by":"publisher","first-page":"e3003284","DOI":"10.1371\/journal.pbio.3003284","volume":"23","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, Xu Y, Ding X, Zhao C, Cheng H, Li G. Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response. PLoS Biol. 2025;23(7):e3003284.","journal-title":"PLoS Biol"},{"issue":"515","key":"3383_CR42","doi-asserted-by":"publisher","first-page":"eaay6863","DOI":"10.1126\/scitranslmed.aay6863","volume":"11","author":"W Held","year":"2019","unstructured":"Held W, Siddiqui I, Schaeuble K, Speiser DE. Intratumoral CD8+ T cells with stem cell\u2013like properties: implications for cancer immunotherapy. Sci Transl Med. 2019;11(515):eaay6863.","journal-title":"Sci Transl Med"},{"issue":"5","key":"3383_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.390","volume":"4","author":"L Xie","year":"2023","unstructured":"Xie L, Fang J, Yu J, Zhang W, He Z, Ye L, et al. The role of CD4+ T cells in tumor and chronic viral immune responses. MedComm. 2023;4(5):e390.","journal-title":"MedComm"},{"key":"3383_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102629","volume":"120","author":"I Negura","year":"2023","unstructured":"Negura I, Pavel-Tanasa M, Danciu M. Regulatory T cells in gastric cancer: key controllers from pathogenesis to therapy. Cancer Treat Rev. 2023;120:102629.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"3383_CR45","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.immuni.2024.01.019","volume":"57","author":"R Ding","year":"2024","unstructured":"Ding R, Yu X, Hu Z, Dong Y, Huang H, Zhang Y, et al. Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells. Immunity. 2024;57(3):528-540.e6.","journal-title":"Immunity"},{"issue":"8","key":"3383_CR46","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/ijc.33873","volume":"150","author":"Y Qu","year":"2022","unstructured":"Qu Y, Wang X, Bai S, Niu L, Zhao G, Yao Y, et al. The effects of TNF-\u03b1\/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer. Int J Cancer. 2022;150(8):1373\u20131391.","journal-title":"Int J Cancer"},{"issue":"2","key":"3383_CR47","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/imm.13520","volume":"168","author":"J Wang","year":"2023","unstructured":"Wang J, Gong R, Zhao C, Lei K, Sun X, Ren H. Human FOXP3 and tumour microenvironment. Immunology. 2023;168(2):248\u2013255.","journal-title":"Immunology"},{"key":"3383_CR48","doi-asserted-by":"publisher","first-page":"940052","DOI":"10.3389\/fimmu.2022.940052","volume":"13","author":"BR McRitchie","year":"2022","unstructured":"McRitchie BR, Akkaya B. Exhaust the exhausters: targeting regulatory T cells in the tumor microenvironment. Front Immunol. 2022;13:940052.","journal-title":"Front Immunol"},{"issue":"2","key":"3383_CR49","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.crimmu.2021.08.002","volume":"1","author":"T Sarkar","year":"2021","unstructured":"Sarkar T, Dhar S, Sa G. Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape. Curr Res Immunol. 2021;1(2):132\u2013141.","journal-title":"Curr Res Immunol"},{"issue":"8","key":"3383_CR50","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1111\/cas.14521","volume":"111","author":"Y Oya","year":"2020","unstructured":"Oya Y, Hayakawa Y, Koike K. Tumor microenvironment in gastric cancers. Cancer Sci. 2020;111(8):2696\u20132707.","journal-title":"Cancer Sci"},{"key":"3383_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395786","volume":"15","author":"B Xu","year":"2024","unstructured":"Xu B, Liu Y, Li N, Geng Q. Lactate and lactylation in macrophage metabolic reprogramming: current progress and outstanding issues. Front Immunol. 2024;15:1395786.","journal-title":"Front Immunol"},{"issue":"9","key":"3383_CR52","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, et al. Lactylation-driven METTL3-mediated RNA m6a modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82(9):1660-1677.e10.","journal-title":"Mol Cell"},{"issue":"22","key":"3383_CR53","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","volume":"271","author":"DR Leach","year":"1996","unstructured":"Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996;271(22):1734\u20131736.","journal-title":"Science"},{"issue":"13","key":"3383_CR54","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma P, Goswami S, Raychaudhuri D, Siddiqui BA, Singh P, Nagarajan A, et al. Immune checkpoint therapy\u2014current perspectives and future directions. Cell. 2023;186(13):1652\u20131669.","journal-title":"Cell"},{"issue":"5","key":"3383_CR55","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/ot9.0000000000000059","volume":"9","author":"XS Li","year":"2023","unstructured":"Li XS, Xia F. Immunotherapy for hepatocellular carcinoma: molecular pathogenesis and clinical research progress. Oncol Transl Med. 2023;9(5):206.","journal-title":"Oncol Transl Med"},{"issue":"1","key":"3383_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-023-01073-9","volume":"13","author":"B Wang","year":"2023","unstructured":"Wang B, Han Y, Zhang Y, Zhao Q, Wang H, Wei J, et al. Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms. Cell Biosci. 2023;13(1):120.","journal-title":"Cell Biosci"},{"issue":"8","key":"3383_CR57","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s40265-022-01723-1","volume":"82","author":"J Paik","year":"2022","unstructured":"Paik J. Nivolumab plus relatlimab: first approval. Drugs. 2022;82(8):925\u2013931.","journal-title":"Drugs"},{"issue":"9","key":"3383_CR58","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.ccell.2023.07.011","volume":"41","author":"SL Topalian","year":"2023","unstructured":"Topalian SL, Forde PM, Emens LA, Yarchoan M, Smith KN, Pardoll DM. Neoadjuvant immune checkpoint blockade: a window of opportunity to advance cancer immunotherapy. Cancer Cell. 2023;41(9):1551\u20131566.","journal-title":"Cancer Cell"},{"issue":"7","key":"3383_CR59","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41568-024-00705-7","volume":"24","author":"AM Holder","year":"2024","unstructured":"Holder AM, Dedeilia A, Sierra-Davidson K, Cohen S, Liu D, Parikh A, et al. Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours. Nat Rev Cancer. 2024;24(7):498\u2013512.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"3383_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1312","volume":"13","author":"Z Han","year":"2023","unstructured":"Han Z, Cheng S, Dai D, Kou Y, Zhang X, Li F, et al. The gut microbiome affects response of treatments in HER2-negative advanced gastric cancer. Clin Transl Med. 2023;13(7):e1312.","journal-title":"Clin Transl Med"},{"issue":"28","key":"3383_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1485580","volume":"14","author":"X Sun","year":"2024","unstructured":"Sun X, Dong H, Su R, Chen J, Li W, Yin S, et al. Lactylation-related gene signature accurately predicts prognosis and immunotherapy response in gastric cancer. Front Oncol. 2024;14(28):1485580.","journal-title":"Front Oncol"},{"issue":"8","key":"3383_CR62","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman MJ, Lonardi S, Wong KYM, Lenz HJ, Gelsomino F, Aglietta M, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018;36(8):773\u2013779.","journal-title":"J Clin Oncol"},{"issue":"7","key":"3383_CR63","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S1470-2045(16)30098-5","volume":"17","author":"SJ Antonia","year":"2016","unstructured":"Antonia SJ, L\u00f3pez-Martin JA, Bendell J, Ott PA, Taylor M, Eder JP, et al. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1\/2 trial. Lancet Oncol. 2016;17(7):883\u2013895.","journal-title":"Lancet Oncol"},{"key":"3383_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116669","volume":"175","author":"X Hou","year":"2024","unstructured":"Hou X, Liu S, Zeng Z, Wang Z, Ding J, Chen Y, et al. Preclinical imaging evaluation of a bispecific antibody targeting hPD1\/CTLA4 using humanized mice. Biomed Pharmacother. 2024;175:116669.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3383_CR65","doi-asserted-by":"publisher","first-page":"2180794","DOI":"10.1080\/19420862.2023.2180794","volume":"15","author":"X Pang","year":"2023","unstructured":"Pang X, Huang Z, Zhong T, Zhang P, Wang ZM, Xia M, et al. Cadonilimab, a tetravalent PD-1\/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity. MAbs. 2023;15(1):2180794.","journal-title":"MAbs"},{"issue":"7","key":"3383_CR66","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1038\/s41591-024-03007-5","volume":"30","author":"X Gao","year":"2024","unstructured":"Gao X, Ji K, Jia Y, Shan F, Chen Y, Xu N, et al. Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b\/2 COMPASSION-04 trial. Nat Med. 2024;30(7):1943\u20131951.","journal-title":"Nat Med"},{"issue":"8","key":"3383_CR67","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/cac2.12193","volume":"41","author":"FH Wang","year":"2021","unstructured":"Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond). 2021;41(8):747\u2013795.","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"3383_CR68","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(2):167\u2013192.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"3383_CR69","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1001\/jama.2023.19918","volume":"330","author":"J Xu","year":"2023","unstructured":"Xu J, Jiang H, Pan Y, Gu K, Cang S, Han L, et al. Sintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: the ORIENT-16 randomized clinical trial. JAMA. 2023;330(5):2064\u20132074.","journal-title":"JAMA"},{"key":"3383_CR70","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078876","volume":"385","author":"MZ Qiu","year":"2024","unstructured":"Qiu MZ, Oh DY, Kato K, Arkenau T, Tabernero J, Correa MC, et al. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial. BMJ. 2024;385:e078876.","journal-title":"BMJ"},{"issue":"11","key":"3383_CR71","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S1470-2045(23)00515-6","volume":"24","author":"SY Rha","year":"2023","unstructured":"Rha SY, Oh DY, Ya\u00f1ez P, Bai Y, Ryu MH, Lee J, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2023;24(11):1181\u20131195.","journal-title":"Lancet Oncol"},{"issue":"9","key":"3383_CR72","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3390\/cancers11091223","volume":"11","author":"Y Shindo","year":"2019","unstructured":"Shindo Y, Hazama S, Tsunedomi R, Suzuki N, Nagano H. Novel biomarkers for personalized cancer immunotherapy. Cancers (Basel). 2019;11(9):1223.","journal-title":"Cancers (Basel)"},{"key":"3383_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216837","volume":"590","author":"S Chen","year":"2024","unstructured":"Chen S, Xu Y, Zhuo W, Zhang L. The emerging role of lactate in tumor microenvironment and its clinical relevance. Cancer Lett. 2024;590:216837.","journal-title":"Cancer Lett"},{"issue":"10","key":"3383_CR74","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","volume":"187","author":"Z Zong","year":"2024","unstructured":"Zong Z, Xie F, Wang S, Wu X, Zhang Z, Yang B, et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 2024;187(10):2375\u20132392.","journal-title":"Cell"},{"issue":"7","key":"3383_CR75","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.molcel.2025.02.011","volume":"85","author":"M Iozzo","year":"2025","unstructured":"Iozzo M, Pardella E, Giannoni E, Chiarugi P. The role of protein lactylation: a kaleidoscopic post-translational modification in cancer. Mol Cell. 2025;85(7):1263\u20131279.","journal-title":"Mol Cell"},{"issue":"2","key":"3383_CR76","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cmet.2024.10.015","volume":"37","author":"R Zhu","year":"2025","unstructured":"Zhu R, Ye X, Lu X, Xiao L, Yuan M, Zhao H, et al. ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion. Cell Metab. 2025;37(2):361\u2013376.","journal-title":"Cell Metab"},{"issue":"8021","key":"3383_CR77","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen H, Li Y, Li H, Chen X, Fu H, Mao D, et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631(8021):663\u2013669.","journal-title":"Nature"},{"issue":"1","key":"3383_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Si W, Xia L, Yin D, Wei T, Tao M, et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer. 2024;23(1):90.","journal-title":"Mol Cancer"},{"issue":"1","key":"3383_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03308-5","volume":"25","author":"W Fan","year":"2024","unstructured":"Fan W, Zeng S, Wang X, Wang G, Liao D, Li R, et al. A feedback loop driven by H3K9 lactylation and HDAC2 in endothelial cells regulates VEGF-induced angiogenesis. Genome Biol. 2024;25(1):165.","journal-title":"Genome Biol"},{"issue":"2","key":"3383_CR80","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wu J, Zhai L, Zhang T, Yin H, Gao H, et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell. 2024;187(2):294-311.e21.","journal-title":"Cell"},{"issue":"1","key":"3383_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01219-0","volume":"19","author":"L Yuan","year":"2020","unstructured":"Yuan L, Xu ZY, Ruan SM, Mo S, Qin JJ, Cheng XD. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance. Mol Cancer. 2020;19(1):96.","journal-title":"Mol Cancer"},{"issue":"1","key":"3383_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01075-y","volume":"31","author":"D Luo","year":"2025","unstructured":"Luo D, Liu Y, Lu Z, Huang L. Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives. Mol Med. 2025;31(1):52.","journal-title":"Mol Med"},{"issue":"1","key":"3383_CR83","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5230\/jgc.2023.23.e10","volume":"23","author":"J Yoon","year":"2023","unstructured":"Yoon J, Kim TY, Oh DY. Recent progress in immunotherapy for gastric cancer. J Gastric Cancer. 2023;23(1):207\u2013223.","journal-title":"J Gastric Cancer"},{"issue":"1","key":"3383_CR84","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10330-022-0611-1","volume":"9","author":"Z Ouyang","year":"2023","unstructured":"Ouyang Z, Tao W, Yu S, Zou M. Advances in pharmacotherapies in cancer-related cachexia*. Oncol Transl Med. 2023;9(1):15.","journal-title":"Oncol Transl Med"},{"issue":"2","key":"3383_CR85","doi-asserted-by":"publisher","first-page":"e100017","DOI":"10.1136\/egastro-2023-100017","volume":"1","author":"F Mokhtari-Esbuie","year":"2023","unstructured":"Mokhtari-Esbuie F, Szeglin B, Rouhani Ravari M, Duncan M, Harmon JW. Pioneering use of genetic analysis for CDH1 to identify candidates for prophylactic total gastrectomy to prevent hereditary diffuse gastric cancer. egastro. 2023;1(2):e100017.","journal-title":"eGastroenterology"},{"issue":"2","key":"3383_CR86","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41422-024-01060-w","volume":"35","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Wang Q, Yao Q, Yang Z, Li W, Cheng X, et al. Nonenzymatic lysine d-lactylation induced by glyoxalase II substrate SLG dampens inflammatory immune responses. Cell Res. 2025;35(2):97\u2013116.","journal-title":"Cell Res"},{"key":"3383_CR87","doi-asserted-by":"crossref","unstructured":"Hou X, Hong Z, Zen H, Zhang C, Zhang P, Ma D, et al. Lactylation in cancer biology: unlocking new avenues for research and therapy. Cancer Communications. 2025;cac2.70054.","DOI":"10.1002\/cac2.70054"},{"key":"3383_CR88","doi-asserted-by":"publisher","DOI":"10.34133\/research.0793","volume":"8","author":"Q Li","year":"2025","unstructured":"Li Q, Zhao R, Shen Y, Guo D, Deng L, Cai R, et al. Lactylation in tumor immune escape and immunotherapy: multifaceted functions and therapeutic strategies. ResearchResearch (Wash D C).2025;8:0793.","journal-title":"Research"},{"issue":"1","key":"3383_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07498-z","volume":"16","author":"J Deng","year":"2025","unstructured":"Deng J, Li Y, Yin L, Liu S, Li Y, Liao W, et al. Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis. 2025;16(1):193.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3383_CR90","doi-asserted-by":"publisher","first-page":"1731942","DOI":"10.1080\/2162402X.2020.1731942","volume":"9","author":"S Van Wilpe","year":"2020","unstructured":"Van Wilpe S, Koornstra R, Den Brok M, De Groot JW, Blank C, De Vries J, et al. Lactate dehydrogenase: a marker of diminished antitumor immunity. Oncoimmunology. 2020;9(1):1731942.","journal-title":"Oncoimmunology"},{"issue":"38","key":"3383_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406333","volume":"11","author":"J Chen","year":"2024","unstructured":"Chen J, Zhao D, Wang Y, Liu M, Zhang Y, Feng T, et al. Lactylated apolipoprotein C-II induces immunotherapy resistance by promoting extracellular lipolysis. Adv Sci. 2024;11(38):2406333.","journal-title":"Adv Sci"},{"issue":"5","key":"3383_CR92","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","volume":"211","author":"MZ Noman","year":"2014","unstructured":"Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, et al. PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014;211(5):781\u2013790.","journal-title":"J Exp Med"},{"issue":"9","key":"3383_CR93","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150846","volume":"132","author":"CM Bailey","year":"2022","unstructured":"Bailey CM, Liu Y, Liu M, Du X, Devenport M, Zheng P, et al. Targeting HIF-1\u03b1 abrogates PD-L1-mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues. J Clin Invest. 2022;132(9):e150846.","journal-title":"J Clin Invest"},{"issue":"1","key":"3383_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01102-5","volume":"14","author":"XC Ding","year":"2021","unstructured":"Ding XC, Wang LL, Zhang XD, Xu JL, Li PF, Liang H, et al. The relationship between expression of PD-L1 and HIF-1\u03b1 in glioma cells under hypoxia. J Hematol Oncol. 2021;14(1):92.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"3383_CR95","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cmet.2023.02.013","volume":"35","author":"CB Nava Lauson","year":"2023","unstructured":"Nava Lauson CB, Tiberti S, Corsetto PA, Conte F, Tyagi P, Machwirth M, et al. Linoleic acid potentiates CD8+ T cell metabolic fitness and antitumor immunity. Cell Metab. 2023;35(4):633-650.e9.","journal-title":"Cell Metab"},{"issue":"23","key":"3383_CR96","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1016\/j.cell.2024.08.029","volume":"187","author":"JG Baldwin","year":"2024","unstructured":"Baldwin JG, Heuser-Loy C, Saha T, Schelker RC, Slavkovic-Lukic D, Strieder N, et al. Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy. Cell. 2024;187(23):6614\u20136630.","journal-title":"Cell"},{"issue":"1","key":"3383_CR97","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccell.2024.11.003","volume":"43","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, Su Y, Xie E, Cheng H, Du J, Xu Y, et al. Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity. Cancer Cell. 2025;43(1):103-121.e8.","journal-title":"Cancer Cell"},{"issue":"1","key":"3383_CR98","volume":"12","author":"T Yang","year":"2025","unstructured":"Yang T, Wang YY, Ma F, Xu BH, Qian HL. Build the virtual cell with artificial intelligence: a perspective for cancer research. Mil Med Res. 2025;12(1):4.","journal-title":"Mil Med Res"},{"issue":"3","key":"3383_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/INMD.20230013","volume":"1","author":"Y Yang","year":"2023","unstructured":"Yang Y, Guan S, Ou Z, Li W, Yan L, Situ B. Advances in AI-based cancer cytopathology. Interdiscip Med. 2023;1(3):e20230013.","journal-title":"Interdiscip Med"},{"issue":"12","key":"3383_CR100","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41568-021-00399-1","volume":"21","author":"O Elemento","year":"2021","unstructured":"Elemento O, Leslie C, Lundin J, Tourassi G. Artificial intelligence in cancer research, diagnosis and therapy. Nat Rev Cancer. 2021;21(12):747\u2013752.","journal-title":"Nat Rev Cancer"},{"key":"3383_CR101","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.semcancer.2023.04.009","volume":"93","author":"Z Wang","year":"2023","unstructured":"Wang Z, Liu Y, Niu X. Application of artificial intelligence for improving early detection and prediction of therapeutic outcomes for gastric cancer in the era of precision oncology. Semin Cancer Biol. 2023;93:83\u201396.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3383_CR102","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-022-03298-7","volume":"20","author":"T Chen","year":"2022","unstructured":"Chen T, Li X, Mao Q, Wang Y, Li H, Wang C, et al. An artificial intelligence method to assess the tumor microenvironment with treatment outcomes for gastric cancer patients after gastrectomy. J Transl Med. 2022;20(1):100.","journal-title":"J Transl Med"},{"issue":"7","key":"3383_CR103","first-page":"3169","volume":"13","author":"Y Nie","year":"2023","unstructured":"Nie Y, Zhao W, Lu L, Zhou F. Predictive biomarkers and new developments of immunotherapy in gastric cancer: a 2023 update. Am J Cancer Res. 2023;13(7):3169\u20133184.","journal-title":"Am J Cancer Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03383-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03383-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03383-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:04:02Z","timestamp":1763139842000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03383-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3383"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03383-9","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1124"}}